[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345843-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345843-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","role-of-pdgf-bb-in-oral-squamous-cell-carcinoma-through-pi3aktmtor-pathway-an-integrated-computational-and-real-time-pcr-based-approach","Role of PDGF-BB in Oral Squamous Cell Carcinoma through PI3/AKT/mTOR Pathway - An Integrated Computational and Real-Time PCR-Based Approach","","This study investigates PDGF-BB’s role in oral squamous cell carcinoma (OSCC) and its influence on the PI3K/AKT/mTOR pathway. It combines in silico network analysis with experimental validation to evaluate PDGF-BB and related signaling molecule expression in OSCC pathogenesis. Serum PDGF-BB protein levels were quantified by ELISA in 30 OSCC patients and 30 matched controls, while PI3K, AKT, and mTOR mRNA were measured using RT-qPCR in OSCC and adjacent non-tumor tissues. Results show elevated PDGF-BB and upregulated pathway transcripts in OSCC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/role-of-pdgf-bb-in-oral-squamous-cell-carcinoma-through-pi3aktmtor-pathway-an-integrated-computational-and-real-time-pcr-based-approach/345843/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/role-of-pdgf-bb-in-oral-squamous-cell-carcinoma-through-pi3aktmtor-pathway-an-integrated-computational-and-real-time-pcr-based-approach/345843.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary objective of the study?","Question",{"text":63,"@type":64},"To determine how PDGF-BB contributes to OSCC and how it affects the PI3K/AKT/mTOR signaling pathway, including expression analysis of PDGF-BB and related signaling molecules.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What methods were used to study PDGF-BB and the pathway?",{"text":68,"@type":64},"The study used a combined in silico approach (UniProt data retrieval, STRING protein-protein interaction analysis, and PANTHER pathway enrichment) and experimental validation using ELISA and quantitative real-time PCR (RT-qPCR).",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding PDGF-BB and PI3K/AKT/mTOR?",{"text":72,"@type":64},"ELISA showed significantly higher serum PDGF-BB in OSCC patients versus controls, and RT-qPCR showed increased mRNA expression of PI3K, AKT, and mTOR in OSCC tissues compared with adjacent non-tumor tissue.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345843,1790172688,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:04/17/2025 Acceptance:01/08/2026 Published:01/21/2026 |\n| --- | --- |\n\nRole of PDGF-BBin Oral Squamous Cell Carcinoma through PI3/AKT/mTOR Pathway: An Integrated Computational and Real-Time PCR-Based Approach  \nGeorgia Benitha 1 *, Pratibha Ramani 2 , Selvaraj Jayaraman3 , Abilasha Ramasubramaniam4, Sandra Sagar5  \nAbstract  \nObjective: This study investigates the role of PDGF-BB in oral squamous cell carcinoma (OSCC) and its impact on the PI3K/AKT/mTOR pathway. The goal is to elucidate the expression levels analysis of PDGF-BB and signaling molecules in OSCC pathogenesis, potentially identifying novel biomarkers or therapeutic targets. Methods: A combined approach involving in silico and experimental methods was employed. Protein sequence data for PDGF-BB were obtained from UniProt, and protein-protein interactions were analyzed using STRING to visualize PDGF-BB’s network. Pathway enrichment analysis was conducted via PANTHER to identify relevant signaling pathways. The study included 30 OSCC patients and 30 matched healthy controls. Serum PDGF-BB protein levels were quantified using enzyme-linked immunosorbent assay (ELISA), while mRNA expression of PI3K, AKT, and mTOR was measured in OSCC and adjacent non-tumor tissues using quantitative real-time PCR (RT-qPCR) . Results: Pathway analysis identified 12 significant signaling pathways associated with PDGF-BB, with the PI3K/AKT/mTOR pathway chosen for validation due to its relevance in cancer-related signaling. STRING analysis confirmed PDGF-BB’s interaction with this pathway. ELISA revealed significantly elevated serum PDGF-BB levels in OSCC patients (3.44 ng/mL) compared to controls (1.38 ng/mL, p \u003C 0.05). RT-qPCR demonstrated significant upregulation of PI3K, AKT, and mTOR mRNA in OSCC tissues, with fold changes of 1.93, 2.1, and 1.9, respectively, relative to adjacent non-tumor tissues. Conclusion: PDGF-BB is significantly upregulated in OSCC and likely contributes to OSCC progression by activating the PI3K/ AKT/mTOR pathway. These findings highlight PDGF-BB’s potential as a biomarker and therapeutic target in OSCC. Targeted therapies aimed at disrupting PDGF-BB and PI3K/AKT/mTOR signaling may improve OSCC outcomes, offering a promising avenue for future research and clinical applications.  \nKeywords: Oral squamous cell carcinoma-PDGF-BB, PI3K/AKT/mTOR pathway-Protein-protein interaction  \nAsian Pac J Cancer Prev, 27 (1), 109-116  \nIntroduction  \nOral squamous cell carcinoma (OSCC) is one of the most common and aggressive cancers ofthe head and neck, accounting for more than 90% of all oral malignancies. Despite advances in treatment techniques such as surgery, chemotherapy, and radiation, the five-year survival rate for individuals with OSCC remains disappointingly low, especially in the advanced stages of the disease. This limited effectiveness in improving long-term outcomes is mostly attributable to the high rates of recurrence and metastasis found in OSCC patients [1, 2] . The persistent  \nlow survival rates, especially in countries where tobacco and alcohol use are prominent, highlight the need for a greater understanding of OSCC’s molecular and genetic origins, which could potentially lead to more successful therapy possibilities [3-5] .  \nOSCC is a complicated disease characterized by several genetic abnormalities, epigenetic alterations, and abnormal cellular pathways. A variety of genes and signaling pathways have been linked to its progression, including the inactivation of tumor suppressor genes, activation of oncogenes, and overexpression of growth factors and receptors [6, 7]. Notably, growth factors like  \n1Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India. 2Department of Oral and Maxillofacial Pathology, Priyadarshini Dental College and Hospitals, India. 3Department of Oral Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of M","cbCaindrmrCIgSpJ","https://ap.wps.com/l/cbCaindrmrCIgSpJ","pdf",810409,"English","# Abstract\n# Objective\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction\n## OSCC background and clinical challenge\n## Growth factors and PDGF-BB in OSCC\n## PDGF signaling and receptor mechanisms","[{\"question\":\"What is the primary objective of the study?\",\"answer\":\"To determine how PDGF-BB contributes to OSCC and how it affects the PI3K/AKT/mTOR signaling pathway, including expression analysis of PDGF-BB and related signaling molecules.\"},{\"question\":\"What methods were used to study PDGF-BB and the pathway?\",\"answer\":\"The study used a combined in silico approach (UniProt data retrieval, STRING protein-protein interaction analysis, and PANTHER pathway enrichment) and experimental validation using ELISA and quantitative real-time PCR (RT-qPCR).\"},{\"question\":\"What were the key findings regarding PDGF-BB and PI3K/AKT/mTOR?\",\"answer\":\"ELISA showed significantly higher serum PDGF-BB in OSCC patients versus controls, and RT-qPCR showed increased mRNA expression of PI3K, AKT, and mTOR in OSCC tissues compared with adjacent non-tumor tissue.\"}]","Role of PDGF-BB in Oral Squamous Cell Carcinoma through PI3/AKT/mTOR Pathway - An Integrated Computational and Real-Time PCR-Based Approach | PDF",1790059080,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfba947d84756a74dd3da111299c1079.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3005383e70c6e0b8907ea2491b65a556.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/312b501c80d353cfc1d69a9fc4d904b1.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72847a9abd69e24c8b18b804ccce6ea2.webp",980,1385]